Life Sciences - Page 32 - Research Triangle Regional Partnership

LabCorp gets FDA approval for pooled Covid-19 testing that increases capacity, saves supplies

July 28, 2020

Seeking to improve turnaround times for Covid-19 testing, Burlington-based LabCorp (NYSE: LH) has received emergency approval from the U.S. Food…

July 28, 2020

Research Triangle Park-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic…

July 27, 2020

A technology for HIV prevention that’s been studied for years by researchers in the Triangle has taken a big leap…

July 27, 2020

RESEARCH TRIANGLE PARK – North Carolina’s global leadership in biomanufacturing has drawn a major spotlight with a White House announcement…

July 27, 2020

CHAPEL HILL – CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been used to…

July 24, 2020

The purpose of President Donald Trump’s upcoming visit to a Triangle biotech is simple: To see where the ‘magic’ happens,…

July 23, 2020

CHAPEL HILL – UNC-Chapel Hill faculty member Meredith Smith works with North Carolina’s clerks of superior court. In their judicial…

July 23, 2020

RESEARCH TRIANGLE PARK – G1 Therapeutics has landed a licensing del worth up to $310 million not counting royalties for…

July 23, 2020

In an effort to assist businesses with safely returning employees to the workplace, Burlington-based LabCorp (NYSE: LH) has embarked on…